Head and Neck Cancer

If you have been NEWLY DIAGNOSED  START HERE 

Cancer Journey


VIDEOS

Drs. Jared Weiss, Assistant Professor, Clinical Research Hematology/Oncology, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, join GRACE to discuss updates relating to pembrolizumab, nivolumab and PD-L1 markers for head and neck cancers.

Drs. Jared Weiss, Assistant Professor, Clinical Research Hematology/Oncology, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, join GRACE to discuss updates relating to pembrolizumab, nivolumab and PD-L1 markers for head and neck cancers.

ARTICLES

In this giving season, we thank you for your generosity. Your donation helps thousands of people living with cancer become educated about their...

Covid-19 Financial Impacts and Resources for the Cancer PatientAs many of you know, the costs of treating a new disease or virus are often...

The staff at GRACE is concerned like everyone regarding the Novel Coronavirus (COVID-19) and are committed to providing information that benefits and...

GRACE is committed to providing the most up to date information regarding cancer diagnoses for our community. We realize an active ongoing discussion...

From the Grace Archives | Originally Published April 22, 2012 | By Dr West | 12 Comments We know that there is a big difference between a lung (or...

COMMUNITY FORUM

Hello, I'm writing on behalf of my 56-year-old uncle, who suffers from recurrent head and neck cancer. His cancer started at the base of the tongue...
Here's another end of year review of new data. Watch out, it's hopeful! "Debio/ Xevinapant Study Update What Have We Learned About Debio 1143...
Here's a new head and neck cancer video. Not only can't I say enough about how much I appreciate learning about new findings but they speak about the...
Here's a new head and neck cancer video. Not only can't I say enough about how much I appreciate learning about new findings but they speak about the...

The research team at Tulane University is conducting an online survey of individuals with cancer. GRACE has been asked to share information about an...

RECENT POSTS

Hi Cal,  Welcome to Grace.  I
Last Comment by JanineT Forum … on Sep 4, 2021 4:00 pm
Hi mickh, Welcome to Grace. 
Last Comment by JanineT Forum … on Jan 12, 2021 11:44 am
Sorry its oesophagus  cancer 
Last Comment by JanineT Forum … on Jan 12, 2021 11:44 am
Hi all i was diagnosed some
Last Comment by JanineT Forum … on Jan 12, 2021 11:44 am
Pancoast tumor
Last Comment by Wileysmolly@gm… on Jul 19, 2020 4:38 pm

ASCO/ESMO 2020 - KEYNOTE 048 Study Update, What Have We Learned?

Here's a new head and neck cancer video.  Not only can't I say enough about how much I appreciate learning about new findings but they speak about the fact that they have different approaches to the same case description.  Just knowing that lets me know I need to discuss my goals and options for treatment when there isn't a clear direction. 

Project Zero Delay: Maybe There is Hope for the Clinical Trials Process After All!

Article

From the GRACE Archives - Originally Published August 26, 2009 | By Dr Pennell 

OK, I hope you all aren’t bored to tears by this topic by now, given two related posts in April and again earlier this month describing the “broken” clinical trials system and the challenges to performing clinical research in the current environment. However, I thought this would be a good follow up post to let all of you know that the laughably obstructionist policies in place that prevent timely processing of clinical trials are being recognized, and that something is being done to fix it.

Head and Neck Cancer Treatment Update: Pembrolizumab, Nivolumab and PD-L1 Markers

Video

Drs. Jared Weiss, Assistant Professor, Clinical Research Hematology/Oncology, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, join GRACE to discuss updates relating to pembrolizumab, nivolumab and PD-L1 markers for head and neck cancers.